This press conference on “Late Breaking Clinical Trials,” held Saturday, April 6, was hosted by AACR President-elect Charles L. Sawyers, M.D., chair of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center, and featured the following research:
Listen to a recording of the teleconference:
- Biomarker Analysis Identified Women Most Likely to Benefit From T-DM1
- Novel Two-step Immunotherapy Showed Promise for Patients With Recurrent Ovarian Cancer
- New Type of Experimental Drug Active in Platinum-resistant Ovarian Cancers
- Immunotherapy Showed Promising Antileukemia Activity in Pediatric Patients
Listen to the teleconference or download* the mp3 of the teleconference (5.26 MB, 46:00 min.)
*On a PC, right mouse click on the "download" link and select "Save link as..." in Firefox or "Save Target as..." in Internet Explorer.